Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Acta Cir Bras ; 31(10): 668-674, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27828600

RESUMO

PURPOSE:: To investigate if the association of fat grafts and platelet-rich plasma (PRP) improves graft viability in female rats. METHODS:: This is an experimental, randomized and blinded study, which involved 47 rats. Fat was harvested from the inguinal region and grafted to the cranial region. The experimental group consisted of PRP-enriched fat grafts (n=22) whilst the control group consisted of fat graft only (n=25). After a 100-day period, the animals were euthanised and the fat grafts were analyzed using scores from 0 (absent) to 4 (abundant), in optical microscopy by two independent and blinded pathologists. RESULTS:: Regarding fat graft cell viability, the PRP group scored moderate/abundant in 63% of cases and the fat graft only group scored absent/slight in 72% of cases (p=0.03). The PRP group also presented lower fat necrosis scores when compared to the fat graft only group (p=0.03). Tumors (dermoid cysts) within the fat grafts were observed in three animals in which the grafts were mixed with PRP. CONCLUSION:: Platelet-rich plasma improves the viability and integration of fat grafts in rats, but more studies are needed to fully understand the exact mechanisms that lead to this improvement and assess the safety of the method for use in humans.


Assuntos
Tecido Adiposo/transplante , Sobrevivência de Enxerto/fisiologia , Plasma Rico em Plaquetas , Crânio/cirurgia , Tecido Adiposo/irrigação sanguínea , Tecido Adiposo/patologia , Animais , Sobrevivência Celular/fisiologia , Feminino , Modelos Animais , Distribuição Aleatória , Ratos Wistar , Valores de Referência , Reprodutibilidade dos Testes , Crânio/patologia , Resultado do Tratamento
2.
Acta cir. bras. ; 31(10): 668-674, Oct. 2016. ilus, tab, graf
Artigo em Inglês | VETINDEX | ID: vti-21008

RESUMO

PURPOSE:To investigate if the association of fat grafts and platelet-rich plasma (PRP) improves graft viability in female rats.METHODS:This is an experimental, randomized and blinded study, which involved 47 rats. Fat was harvested from the inguinal region and grafted to the cranial region. The experimental group consisted of PRP-enriched fat grafts (n=22) whilst the control group consisted of fat graft only (n=25). After a 100-day period, the animals were euthanised and the fat grafts were analyzed using scores from 0 (absent) to 4 (abundant), in optical microscopy by two independent and blinded pathologists.RESULTS:Regarding fat graft cell viability, the PRP group scored moderate/abundant in 63% of cases and the fat graft only group scored absent/slight in 72% of cases (p=0.03). The PRP group also presented lower fat necrosis scores when compared to the fat graft only group (p=0.03). Tumors (dermoid cysts) within the fat grafts were observed in three animals in which the grafts were mixed with PRP.CONCLUSION:Platelet-rich plasma improves the viability and integration of fat grafts in rats, but more studies are needed to fully understand the exact mechanisms that lead to this improvement and assess the safety of the method for use in humans.(AU)


Assuntos
Animais , Ratos , Transplantes , Plasma Rico em Plaquetas , Tecido Adiposo/transplante , Sobrevivência de Enxerto
3.
Acta cir. bras ; Acta cir. bras;31(10): 668-674, Oct. 2016. tab, graf
Artigo em Inglês | LILACS | ID: biblio-827655

RESUMO

ABSTRACT PURPOSE: To investigate if the association of fat grafts and platelet-rich plasma (PRP) improves graft viability in female rats. METHODS: This is an experimental, randomized and blinded study, which involved 47 rats. Fat was harvested from the inguinal region and grafted to the cranial region. The experimental group consisted of PRP-enriched fat grafts (n=22) whilst the control group consisted of fat graft only (n=25). After a 100-day period, the animals were euthanised and the fat grafts were analyzed using scores from 0 (absent) to 4 (abundant), in optical microscopy by two independent and blinded pathologists. RESULTS: Regarding fat graft cell viability, the PRP group scored moderate/abundant in 63% of cases and the fat graft only group scored absent/slight in 72% of cases (p=0.03). The PRP group also presented lower fat necrosis scores when compared to the fat graft only group (p=0.03). Tumors (dermoid cysts) within the fat grafts were observed in three animals in which the grafts were mixed with PRP. CONCLUSION: Platelet-rich plasma improves the viability and integration of fat grafts in rats, but more studies are needed to fully understand the exact mechanisms that lead to this improvement and assess the safety of the method for use in humans.


Assuntos
Animais , Feminino , Crânio/cirurgia , Tecido Adiposo/transplante , Plasma Rico em Plaquetas , Sobrevivência de Enxerto/fisiologia , Valores de Referência , Crânio/patologia , Distribuição Aleatória , Sobrevivência Celular/fisiologia , Tecido Adiposo/irrigação sanguínea , Tecido Adiposo/patologia , Reprodutibilidade dos Testes , Resultado do Tratamento , Ratos Wistar , Modelos Animais
4.
Chest ; 132(2): 477-82, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17505032

RESUMO

INTRODUCTION: Patients with COPD have decreased exercise capacity and low oxygen consumption (Vo(2)) during formal cardiopulmonary exercise testing, and lower scores on health-related quality of life questionnaires. When isolated, these three variables show different correlations with COPD mortality. The multidimensional BODE (body mass index[BMI], airflow obstruction, dyspnea, and exercise capacity in COPD) index, which comprises four variables including the 6-min walk test (6MWT), predicts survival in COPD. OBJECTIVES: To evaluate the degree of association between the values of the BODE index using the 6MWT with the BODE index using maximal Vo(2) (Vo(2)max) obtained in a maximal incremental test. MATERIALS AND METHODS: Fifty patients with mild-to-severe COPD (average age, 63.5 +/- 9.9 years; FEV(1), 65.3 +/- 23.6% of predicted) [+/- SD] had BMI, spirometric function (FVC and FEV(1)), and dyspnea status (Medical Research Council) evaluated. Two BODE index scores were then completed: one with the 6MWT, and one with the Vo(2)max obtained during maximal incremental testing on a treadmill. RESULTS: Correlation between BODE index and Vo(2) in milliliters per minute per kilogram (r = - 0.41) was weak; the correlation was moderate (r = - 0.64) when Vo(2) percentage of predicted was used. The BODE index modified by replacing the 6MWT with Vo(2) showed excellent correlations with Vo(2) in milliliters per minute per kilogram (r = 0.92) and Vo(2) percentage of predicted (r = 0.95). CONCLUSION: The excellent correlation between the conventional BODE index and the modified BODE index with Vo(2) replacing the 6MWT enables us to reach the conclusion that the original BODE index is very effective in the evaluation of COPD patients.


Assuntos
Índice de Massa Corporal , Tolerância ao Exercício/fisiologia , Consumo de Oxigênio/fisiologia , Doença Pulmonar Obstrutiva Crônica , Caminhada/fisiologia , Brasil/epidemiologia , Teste de Esforço , Volume Expiratório Forçado/fisiologia , Humanos , Pessoa de Meia-Idade , Prognóstico , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/mortalidade , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Testes de Função Respiratória , Índice de Gravidade de Doença , Taxa de Sobrevida/tendências , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA